Freestanding emergency departments may increase out-of-pocket spending for patients
With emergency department visits spiking around the holidays, patients may be inclined to seek care at freestanding emergency departments in
Read more
Study examines safety-net care for US patients on maintenance dialysis
New research indicates that non-profit/independently-owned and hospital-based dialysis facilities care disproportionately for uninsured patients with kidney failure and those who
Read more
Researchers support new strategies for HIV control
The search for an AIDS cure has partly focused on ways to eradicate infected cells. Now, new research from Karolinska
Read more
Multiple sclerosis: New standards required for planning clinical trials
How can the perspectives of patients with multiple sclerosis (MS) be given more consideration in clinical trials? This question was
Read more
Standard of care chemoradiation for stage III non-small cell lung cancer is superior to two tested alternatives
Lung cancer is the leading cause of cancer death in the United States and approximately 75-80 percent of all cases
Read more
1999 to 2017 saw drop in IBD hospitalization rate for whites
From 1999 to 2017, the hospitalization rate for Crohn disease and ulcerative colitis decreased among non-Hispanic white Medicare beneficiaries aged
Read more
People willing to risk near-certain death for an HIV cure
Nearly one-quarter of people living with HIV were willing to risk near-certain death in a clinical trial, if volunteering for
Read more
Out-of-network costs soar for non-emergency hospitalizations
The out-of-pocket financial burden for insured working Americans is substantial and growing—especially when it comes to out-of-network, non-emergency hospital care,
Read more
Team investigates why candidates for cochlear implants rarely get them
Many hearing loss patients are cochlear implant candidates, but few use this technology that could improve their hearing and quality
Read more
Immunotherapy drug improves outcomes for some children with relapsed leukemia
New findings from a clinical trial show that treatment with the immunotherapy drug blinatumomab is superior to standard chemotherapy for
Read more